To date it is not known whether this alteration in IGF-I binding is a feature of obesity or Prader Willi syndrome, but it is noteworthy that the cohort of patients reported in this study were not obese (mean BMI SDS 1.2, inter quartile range 0.2–1.7). The gene discussed is IGF1; the disease is obesity disorder.